Nexthera Capital

Latest statistics and disclosures from Nexthera Capital's latest quarterly 13F-HR filing:

Portfolio Holdings for Nexthera Capital

Companies in the Nexthera Capital portfolio as of the June 2019 quarterly 13F filing

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Intercept Pharmaceuticals In 10.10 152441 +1175% 79.57
Insmed Inc 10.04 470741 +65% 25.60
Audentes Therapeutics Inc Com stock 9.27 294013 +17% 37.86
Neurocrine Biosciences (NBIX) 6.50 92380 +284% 84.43
Sarepta Therapeutics 6.37 50317 +136% 151.96
Global Blood Therapeutics In 6.23 142305 +63% 52.60
Immunomedics (IMMU) 6.05 524140 +56% 13.87
Coherus Biosciences 5.82 316316 NEW 22.10
Ascendis Pharma A S 5.78 60266 NEW 115.16
Pacira Pharmaceuticals, Inc. 5.40 149086 NEW 43.49
Urogen Pharma 5.29 176866 +33% 35.94
Uniqure Nv shs 3.90 59883 +54% 78.15
Amarin Corporation (AMRN) 3.72 230295 +54% 19.39
Abbvie 3.19 52681 NEW 72.72
Biohaven Pharmaceutical Holding 3.14 86165 NEW 43.79
Mylan Nv 1.63 102560 NEW 19.04
Intra Cellular Therapies 1.55 143665 NEW 12.98
Regeneron Pharmaceuticals (REGN) 1.48 5668 NEW 312.99
Madrigal Pharmaceuticals 1.35 15423 +346% 104.78
Dermira 1.10 138102 NEW 9.56
Gilead Sciences (GILD) 1.05 18697 NEW 67.55
Anaptysbio Inc Common 0.57 12026 NEW 56.46
Allergan 0.47 3347 -75% 167.31

Past Filings by Nexthera Capital

View past SEC 13F filings by Nexthera Capital

View all filings